PHAR vs TGTX
Pharming Group N.V. · TG Therapeutics, Inc.
Relative return (rebased to 100)
Key stats
| Metric | PHAR | TGTX |
|---|---|---|
| Price | $10.85 | $49.55 |
| Market Cap | $7.61B | $7.59B |
| P/E | 2670.37 | 16.96 |
| P/B | 27.47 | 13.01 |
| P/S | 20.24 | 12.31 |
| ROE | 1.0% | 76.7% |
| Net Margin | 0.8% | 72.6% |
| Gross Margin | 87.9% | — |
| Revenue Growth | 26.6% | 87.3% |
| Dividend Yield | — | — |
| EPS | $0.00 | $2.92 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.